Atlas Trials

Correlation Between Serum TK1 and Pathological Remission of Breast Cancer With Neoadjuvant Chemotherapy

Clinical trial NCT06509555 · UNKNOWN

Trial details

NCT number
NCT06509555
Sponsor
Yunnan Cancer Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Breast NeoplasmsTK1
Start date
2024-03-01
Primary completion
2026-02-28
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.